Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Günther Konwalinka"'
Autor:
Reinhard Kofler, Nicole Bacher, Martin Tiefenthaler, Hermann Stuppner, Sonja Sturm, Michael J. Ausserlechner, Günther Konwalinka
Publikováno v:
British Journal of Haematology. 132:615-622
Natural products are still an untapped source of promising lead compounds for the generation of antineoplastic drugs. Here, we investigated for the first time the antiproliferative and apoptotic effects of highly purified oxindole alkaloids, namely i
Autor:
Gertrud Haas, Markus Geiger, Wolfgang Göttinger, Manfred Frick, Günther Konwalinka, Monika Ritsch-Marte, Hartwig P. Huemer, Wolfgang Singer, Eveline U. Irschick
Publikováno v:
Ophthalmic Research. 38:164-174
Retinal pigment epithelial (RPE) cells provide crucial functions for the maintenance of the retinal environment. We investigated the phagocytotic mechanisms of RPE cells evaluating the question whether particle uptake underlies a diurnal rhythm. Addi
Autor:
Karl-Hans Ongania, Nigel B. Perry, R. Schwaha, Christian Zidorn, K. Joehrer, Hermann Stuppner, Richard Greil, Ernst-Peter Ellmerer, Günther Konwalinka
Publikováno v:
ResearcherID
Autor:
Hermann Stuppner, Günther Konwalinka, Nadja Schwaiger, Ernst-Peter Ellmerer, Christian Zidorn
Publikováno v:
Tetrahedron Letters. 45:3433-3436
Apart from a number of known sesquiterpenoids, a novel chlorinated sesquiterpene lactone glucoside––13-chloro-3-O-β-d-glucopyranosylsolstitialin––has been isolated from the Southwestern European plant Leontodon palisae (Asteraceae, tribe Lac
Autor:
Oliver Mühlmann, Günther Konwalinka, Nicole Bacher, Martin Tiefenthaler, Elisabeth M. C. Strasser-Wozak, Florian Hohla, Wolfgang Wein
Publikováno v:
STEM CELLS. 21:266-271
In phase I and II clinical trials, the deoxycytidine analogue 2',2' difluorodeoxycytidine (dFdC, gemcitabine) has shown promising antitumor activity in leukemia as well as in solid tumors. Preclinical and clinical studies of gemcitabine suggested tha
Autor:
Wolfgang Wein, Nicole Bacher, Oliver Mühlmann, Günther Konwalinka, Martin Tiefenthaler, EU Irschick, Elisabeth M. C. Strasser-Wozak, Florian Hohla
Publikováno v:
Immunobiology. 207:149-157
The effect of 2',2'-difluorodeoxycytidine (dFdC) on in vitro human lymphocyte response was assessed in comparison with that of its major metabolite 2',2'-difluorodeoxyuridine (dFdU). Peripheral blood mononuclear cells (PBMNC) from healthy human volun
Autor:
Martin Tiefenthaler, Bernd L. Hartmann, Nicole Bacher, Raimund Margreiter, Reinhard Kofler, Albert Amberger, Günther Konwalinka
Publikováno v:
British Journal of Haematology. 114:574-580
Acute tumour-lysis syndrome (ATLS) is a frequently fatal complication after cytoreductive leukaemia therapy. Lactic acidosis is associated with ATLS and its extent is correlated with the severity of ATLS. In the course of cytoreductive therapy, apopt
Publikováno v:
Scandinavian Journal of Rheumatology. 26:376-379
Cladribine (2-chlorodeoxyadenosine, 2-CdA) is a newer purine analog with specific toxicity to lymphocytes. As lymphocytes play a major role in rheumatoid arthritis (RA), we assessed the safety profile of low-dose 2-CdA in patients who were refractory
Autor:
Josef Thaler, Kurt Grünewald, Wolfgang Hilbe, Michael A. Fridrik, Heinz Sill, T. Fluckinger, Herwig Niessner, Dietmar Geissler, Christoph Duba, Marianne Bernhart, Klaus Abbrederis, Manfred Stöger, H. L. Seewann, Werner Linkesch, Hubert Hausmaninger, Heinz Ludwig, Ute Apfelbeck, Richard Greil, Günther Konwalinka, Alois Lang, Jörg Pont, Werner Lin, Dietger Niederwieser
Publikováno v:
Leukemia Research. 21:75-80
Small pilot studies of patients with CML have reported on encouraging response rates after treatment with interferon-alpha (IFNalpha) in combination with low-dose cytosine arabinoside (LD ara-C). We therefore initiated a multi-center phase II trial i
T Cells and Natural Killer Cells after Treatment of Hairy Cell Leukaemia with 2-Chlorodeoxyadenosine
Publikováno v:
Acta Haematologica. 97:180-183
We report that continuous suppression of CD4+ lymphocyte subsets does not necessarily lead to an increased rate of infections more than 6 months after treatment of hairy cell leukemia (HCL) with 2-chlorodeoxyadenosine (cladribine; 2-CdA). In a retros